MNK is testing a lot of weekly resistance in this area, volume really needs to show up.
Short borrow cost increased 20% in 30 days to 23%. Great opportunity to play a squeeze, especially with Feb earnings!
With 67% of the float short and a borrow rate of over 6%, shorts won't stick around forever during this sideways move. Everyday they wait to cover eats away at their profits. Unfortunately, the drop was impressive! Be on the lookout for a couple squeezes.
This weak downgrade provided me an entry point for a few more shares. Morgan Stanley downgrades DocuSign from Overweight to Equal Weight and raises the target from $67 to $76. The company has a Bullish average Sell Side rating. The firm remains positive on DOCU's long-term prospects but sees the opportunities as priced in at the current valuation.
If you missed your entry into CGC, we blew through months of short term resistance. You might be able to get a good entry at the neckline (on a longer retrace) but a more likely shorter pullback to $23 before extending further into this move.
I guess a $1.00 price target was better than $0 but this channel is disgusting... Congrats shorts... Plenty more room to fall.
My earlier call was a bust and we saw MNK bounce nicely off the .382 FIB and maintain the ascending triangle pattern. I expect a pullback from today's gains, unlikely to bounce in the trend line, will set my entry and I think we will test 3.90's before earnings. Ascending triangles can form a reversal pattern at the end of a downtrend, but they are typically...
I just wanted to share that Harvest is really respecting the FIB levels on this short term up swing.
Interesting that CGC is stagnant, refusing to breakout, when the rest of the sector is up big.
APHA continues to try and break out and hopefully completes its inverse head and shoulders. Earnings are right around the corner and could send this skyrocketing!
The volume came but it wasn't sustained. Still awaiting breakout (or failure)
Pretty solid break out of the trend on one of the stronger cannabis stocks. I expect to see a slight recovery from the ACB double downgrade today ($1) and ACB retail sellers to try and pick a replacement cannabis winner.
Weekly chart showing that SNAP is trying to break out. Strong volume yesterday but will it hold. I think SNAP fails to break out (even in this ridiculous market) and falls.
You ever wish for bad earnings just so you can buy the dip? Still in my long position. UHC is giving back Rx rebates at the point of sale, I wonder how that will affect its 2020 earnings potential.